County
La Porte County Emergency Medical Service
The current listed document is more than 24 months old and may be outdated.
Drugs and doses27
A–C Adenosine, Albuterol, Aspirin, Atropine, Calcium Chloride5
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | pages 28, 81, 91, 142 |
| Other | adult | 6 mg | IV | not captured | standing | page 28 |
| Other | adult | 6 mg | IV | not captured | standing | page 142 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 28, 81, 91, 142 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 81 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 160 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5 mg | NEB | not captured | standing | pages 40, 85, 91 |
| Allergic reaction | peds | 2.5 mg | NEB | not captured | standing | pages 40, 85, 91 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 41, 84, 91 |
| CHF / pulmonary edema | adult | 2.5 mg | NEB | not captured | standing | pages 43, 91 |
| COPD | adult | 2.5 mg | NEB | not captured | standing | pages 42, 91 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 42 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 84 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 27, 142 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 0.5 mg | IV | not captured | standing | page 49 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 0.5 mg | IV | not captured | standing | page 49 |
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 30, 78, 91, 142 |
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 142 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 30, 78, 91, 142 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO/ET | not captured | standing | pages 78, 91, 160 |
| Organophosphate poisoning | adult | 2 mg | IV | not captured | standing | pages 50, 89, 91, 142 |
| Organophosphate poisoning | adult | 2 mg | IV | not captured | standing | page 50 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | pages 50, 89, 91, 142 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO/ET | not captured | standing | page 160 |
| Other | adult | 1 mg | IV/IM | not captured | standing | page 30 |
| Other | adult | 2 mg | IV | not captured | standing | page 142 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | page 91 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV | not captured | standing | pages 49, 89, 92, 160, 163 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV | not captured | standing | pages 49, 89 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | pages 49, 89, 92, 160, 163 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | pages 49, 89 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 89 |
| Hyperkalemia | adult | 1 g | IV | not captured | standing | pages 47, 70, 160, 163 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | pages 47, 70, 160, 163 |
| Other | adult | 1 g | IV | not captured | standing | page 70 |
| Other | adult | 10 mL | IV | not captured | standing | page 47 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | pages 160, 163 |
D–F Dextrose, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl, Flumazenil, Furosemide9
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | pages 53, 55, 76, 83, 92, 161 |
| Hypoglycemia | adult | 25 g | IV | not captured | standing | page 53 |
| Hypoglycemia | peds | 0.5 g/kg | IV | not captured | standing | pages 53, 55, 76, 83, 92, 161 |
| Neonatal resuscitation | peds | 5 mL/kg | IV/IO | not captured | standing | page 76 |
| Other | adult | 12.5 g | IV | not captured | standing | page 55 |
| Other | peds | 1 mL/kg (max 25 g) | IV/IO | not captured | standing | page 92 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | page 92 |
| Other | peds | 5 mL/kg | IV/IO | not captured | standing | page 83 |
| Other | peds | 5 mL/kg | IV/IO | not captured | standing | page 92 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | pages 29, 143 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25 mg | IV/IM | not captured | standing | page 143 |
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | pages 40, 85, 92, 143, 160 |
| Allergic reaction | peds | 0.5 mg/kg | IV/IM | not captured | standing | pages 40, 85, 92, 143, 160 |
| Allergic reaction | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 92 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 40 |
| Other | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 85 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 141, 144 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 141, 144 |
| Other | adult | 2–5 mcg/kg | IV/IO | not captured | standing | pages 141, 144 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 40, 85, 92 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 40, 85, 92 |
| Anaphylaxis | peds | 0.01 mg/kg | IV | not captured | standing | pages 40, 85, 92 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | pages 41, 84, 92 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 41, 84, 92 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 78, 92 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 32, 33, 34, 79, 80, 92 |
| Other | peds | 0.01 mg/kg | not captured | not captured | standing | page 84 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 79, 92 |
| VF / pulseless VT | adult | 1 mg | IV | not captured | standing | page 32 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 144, 155 |
| Procedural sedation | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 144, 155 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 100, 103, 155 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25–50 mcg | IV/IM | not captured | standing | page 27 |
| Other | adult | 1 mcg/kg | IV/IM | not captured | standing | pages 68, 69, 70, 93, 100, 102, 154 |
| Other | adult | 1 mcg/kg | IV | not captured | standing | pages 68, 69, 70, 144, 154 |
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | page 100 |
| Other | adult | 2 mcg/kg | IV/IO | not captured | standing | pages 100, 102 |
| Other | peds | 1 mcg/kg | IV/IM | not captured | standing | pages 68, 69, 70, 93, 100, 102, 154 |
| Other | peds | 1 mcg/kg | IV | not captured | standing | pages 93, 154 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | page 100 |
Flumazenil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Benzodiazepine overdose | adult | 0.2 mg | IV | not captured | standing | pages 49, 89, 93, 147, 163 |
| Benzodiazepine overdose | peds | 0.01 mg/kg | IV | not captured | standing | pages 49, 89, 93, 147, 163 |
| Other | adult | 0.2 mg | IV | not captured | standing | pages 101, 147, 163 |
| Other | adult | 0.2 mg | IV | not captured | standing | page 49 |
| Other | peds | 0.01 mg/kg | IV | not captured | standing | pages 101, 147, 163 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 163 |
| Other | peds | 0.2 mg | IV | not captured | standing | page 101 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | pages 43, 145 |
G–L Glucagon, Ipratropium, Ketamine, Lidocaine4
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 53, 83, 93, 145, 162 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 53, 83, 93, 145, 162 |
| Hypoglycemia | peds | 0.1 mg/kg | IV/IM/SQ | not captured | standing | page 162 |
| Other | adult | 2 mg | IV | not captured | standing | page 145 |
| Other | peds | 0.1 mg/kg | IM/SQ | not captured | standing | page 83 |
| Other | peds | 0.1 mg/kg | IV/IM/SQ | not captured | standing | page 93 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | pages 40, 41, 84, 85, 91 |
| Allergic reaction | peds | 0.25 mg | NEB | not captured | standing | pages 40, 41, 84, 85, 91 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 41, 84, 91 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | pages 41, 84, 91 |
| CHF / pulmonary edema | adult | 0.5 mg | NEB | not captured | standing | pages 43, 91 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | pages 42, 91 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 84 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO | not captured | standing | pages 145, 157 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 145 |
| Other | adult | 1 mg/kg | not captured | not captured | standing | pages 104, 158 |
| Other | peds | 1 mg/kg | not captured | not captured | standing | pages 104, 158 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | pages 100, 104, 158 |
| Post-intubation sedation | adult | 1 mg/kg | not captured | not captured | standing | pages 145, 158 |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | standing | pages 100, 103, 157 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 145 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | page 31 |
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | page 145 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 32 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 145 |
| Other | peds | 1 mg/kg | IV/IO/ET | not captured | standing | pages 80, 93, 162 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 93 |
| Mild to moderate pain | adult | 0.5 mg/kg | IO | not captured | standing | pages 118, 120 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 118, 120 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV | not captured | standing | pages 31, 32, 80, 93, 145 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV | not captured | standing | pages 31, 32, 80, 93, 145 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV | not captured | standing | pages 32, 80, 93, 145 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | pages 32, 80, 93, 145 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 41, 84, 93, 140, 145, 162 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | pages 41, 84, 93, 140, 145, 162 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV | not captured | standing | pages 58, 145 |
| Other | adult | 2 g | IV | not captured | standing | pages 32, 41, 140, 145 |
| Other | adult | 5 g | IV | not captured | standing | page 58 |
| Other | peds | 50 mg/kg | IV | not captured | standing | pages 80, 84, 93, 162 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 32, 80, 93, 140, 145, 162 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 32, 80, 93, 140, 145, 162 |
| VF / pulseless VT | peds | 50 mg/kg | IV | not captured | standing | pages 32, 80, 93, 140, 145, 162 |
| VF / pulseless VT | peds | 50 mg/kg | IV | not captured | standing | pages 32, 80, 93, 140, 145, 162 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV | not captured | standing | pages 40, 85, 94, 163 |
| Allergic reaction | peds | 2 mg/kg | IV | not captured | standing | pages 40, 85, 94, 163 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | pages 41, 84, 94, 163 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | pages 41, 84, 94, 163 |
| COPD | adult | 125 mg | IV | not captured | standing | pages 42, 94, 163 |
| Other | adult | 125 mg | IV | not captured | standing | page 42 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | page 51 |
| Other | adult | 2.5–5 mg | IV | not captured | standing | pages 52, 86 |
| Other | adult | 2.5–5 mg | IV | not captured | standing | page 51 |
| Other | adult | 2.5–5 mg | IV/IO | not captured | standing | page 100 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 28 |
| Other | adult | 2.5 mg | IV/IM | not captured | standing | page 30 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 147 |
| Other | adult | 2.5–5 mg | IV | not captured | standing | page 147 |
| Other | adult | 5 mg | IN | not captured | standing | pages 52, 86, 87 |
| Other | adult | 5 mg | IM/IN | not captured | standing | page 51 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 81 |
| Other | peds | 0.2 mg/kg | IN | not captured | standing | pages 52, 86, 87 |
| Other | peds | 0.2 mg/kg | IV | not captured | standing | pages 52, 86 |
| Other | peds | 0.2 mg/kg | IN | not captured | standing | page 86 |
| Other | peds | 0.2 mg/kg | IV | not captured | standing | page 86 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM | not captured | standing | page 30 |
| Procedural sedation | adult | 2.5 mg | IV | not captured | standing | pages 28, 29, 81 |
| Procedural sedation | peds | 0.1 mg/kg | IV | not captured | standing | pages 28, 29, 81 |
| RSI induction | adult | 2.5–5 mg | IV/IO/IM | not captured | standing | pages 100, 147 |
| RSI induction | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 100, 147 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 2 mg | IV | not captured | standing | pages 48, 88, 93, 146, 162 |
| Opioid overdose | adult | 2 mg | NEB | not captured | standing | pages 48, 88, 93, 146 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 48, 88, 93, 146, 162 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | pages 48, 88, 93, 146, 162 |
| Opioid overdose | peds | 0.1 mg/kg | NEB | not captured | standing | pages 48, 88, 93, 146 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 93 |
| Opioid overdose | peds | 0.1 mg/kg | NEB | not captured | standing | page 93 |
| Other | peds | 0.1 mg/kg | NEB | not captured | standing | page 88 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 27 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 43 |
| Other | adult | 1 tablet | SL | not captured | standing | page 17 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2–20 mcg | IV | not captured | standing | pages 35, 46, 71, 93, 146 |
| Cardiogenic shock | adult | 2–20 mcg | not captured | not captured | standing | page 35 |
| Cardiogenic shock | peds | 2–20 mcg | IV | not captured | standing | pages 35, 46, 71, 93, 146 |
| Hypotension / shock | adult | 2–20 mcg | IV | not captured | standing | pages 35, 46, 71, 93, 146 |
| Hypotension / shock | peds | 2–20 mcg | IV | not captured | standing | pages 35, 46, 71, 93, 146 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | pages 27, 54, 147 |
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | pages 27, 54, 147 |
P–R Rocuronium1
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 100, 104, 147, 156 |
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 156 |
| RSI induction | peds | 1 mg/kg | IV | not captured | standing | page 156 |
S–Z Sodium Bicarbonate1
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asystole / PEA | adult | 1 mEq/kg | IV | not captured | standing | pages 33, 94, 163 |
| Asystole / PEA | adult | 1 mEq/kg | IV | not captured | standing | pages 34, 94, 163 |
| Asystole / PEA | peds | 1 mEq/kg | IV | not captured | standing | pages 33, 94, 163 |
| Asystole / PEA | peds | 1 mEq/kg | IV | not captured | standing | pages 34, 94, 163 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 33 |
| Other | adult | 50 mEq | IV | not captured | standing | page 47 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 163 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 33, 34, 48, 88, 94, 163 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 33, 34, 48, 88, 94, 163 |
Cite this
La Porte County Emergency Medical Service, United States EMS Protocol Census. 184 dose entries, effective 2024-03-01.
https://protoquiz.com/census/agencies/la-porte-county-emergency-medical-service/
The census is free and not for sale. Only public agencies are named.